Doravirina+Lamivudina+Tenofovir + Doravirine + Lamivudine + Tenofovir + Tenofovir Disoproxil

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandComposition & strengthManufacturer
DELSTRIGOCA CZ ES EU GB HK LV MX TW US
  • tablet ×4 Doravirine 100 mg + Lamivudine 300 mg + Tenofovir Disoproxil 300 mg
  • tablet ×3 Doravirine + Lamivudine + Tenofovir Disoproxil
  • tablet ×2 Doravirine 100 mg + Lamivudine 300 mg + Tenofovir 245 mg
  • tablet Doravirina+Lamivudina+Tenofovir 100 mg

Other 2 compositions

MERCK SHARP & DOHME LTD., NEW JERSEY

Same combination in other markets

Cross-market comparison is not available for this grouped name.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.